BIRC5 and melanoma: In addition to the approaches mentioned, considerable effort is being placed on the development of survivin-based vaccines (survivin mRNA and peptide) for the treatment of several different types of cancer, including breast cancer, kidney cancer, advanced melanomas and ovarian cancer (Table 1).